If you’re used to buying shares on the stock market, it doesn’t have to be a big leap to invest in unlisted companies as well. At Sciety, we frequently receive questions from people who are considering making their first investment in an unlisted company. Practically speaking, how does it work?…
Read more
Neurological disorders have been pinpointed by WHO as one of the greatest threats to public health. As an example, nearly 10 million people develop dementia each year and the number of people living with dementia is expected to triple from 50 million to 152 million by 2050. Today, the annual…
Read more
Sciety becomes a member in the trade association SwedenBIO that works for a strong life science sector in Sweden. The members include micro companies to big pharma but also companies that provide services in business development, IP, financing and etc. As Sciety works with financing of unlisted companies, in the…
Read more
The new issue of shares in EMPE Diagnostics was fully subscribed already two weeks before the subscription period expired. EMPE Diagnostics develops a rapid test for diagnosis of tuberculosis. In total, 10 million SEK was invested and the funding will be used for final product validation and market launch. …
Read more
Last week, the trade associations LIF, Swedish Medtech and SwedenBIO presented an action plan to strengthen the competitiveness of Swedish life science. As Sciety meets many companies that develop the healthcare sector, we find it is very interesting that one of the three topics in the plan is to introduce…
Read more
Sciety closes a financing round of 10 million SEK and welcomes thirty new shareholders with backgrounds in the finance and healthcare sectors. The largest investor is the investment company Linc. Sciety is an investment platform focusing on unlisted growth companies in the healthcare sector. Since Sciety’s launch during the autumn…
Read more
One week ago, the medical technology company Attana that previously raised funding via Sciety listed its shares on the NGM stock exchange. The company has developed technology to improve efficiency in the development of new drugs and is the second company financed by Sciety to be listed. Sciety…
Read more
Ett trettiotal affärsänglar går in med 20 miljoner kronor i diagnostikbolaget som med sin innovativa mjukvara ska bekämpa det globala hotet från antibiotikaresistens. Investeringarna sker via Sciety som är specialiserat på tillväxtbolag inom hälsa och medicin. Med 1928 Diagnostics mjukvara kan man med hjälp av teknik som redan finns på…
Read more
The investments come partly from a business angel network and a venture capital company that already owns shares in the company and partly from new financiers, each investing from some thousand SEK up to a couple of million SEK. In total, the company raised 6 million SEK for its continued…
Read more- « Previous
- 1
- 2
- 3